Funding for Projects on “Application of Artificial Intelligence (AI) in Drug Discovery”

This funding program was aimed at various actors from science, industry, and the non-profit sector in Germany who pursued innovative approaches to the application of Artificial Intelligence in drug discovery.

The program supported thematic research and innovation in the health and social sectors, particularly projects on the application of Artificial Intelligence in drug discovery.

The funding program provided financial support in the form of grants. Specific details on maximum funding amounts or funding rates were not included in the document.

Important conditions concerned the submission of project outlines, the deadline for which was April 30, 2025. Further detailed specifications on consortia, de minimis regulations, or budget restrictions were not explicitly listed.

The application process involved the submission of project outlines via electronic systems. The evaluation of applications was carried out by Projektträger Jülich.

The legal basis of the funding program was a specific guideline of the Federal Ministry of Education and Research, published in the Federal Gazette.